ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,265 | -51,609 | -44,960 | -32,226 | -17,251 |
| Depreciation Amortization | 31 | 148 | 118 | 83 | 42 |
| Other Working Capital | -980 | 1,817 | 4,533 | 4,654 | 5,743 |
| Other Operating Activity | 3,524 | 1,774 | 3,364 | 3,128 | 992 |
| Operating Cash Flow | $-7,689 | $-47,870 | $-36,945 | $-24,362 | $-10,474 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -8 | N/A | 0 | 0 | 0 |
| PPE Investments | -54 | -720 | -646 | -543 | -221 |
| Investing Cash Flow | $-62 | $-720 | $-646 | $-543 | $-221 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 68,894 | 69,036 | 23,875 | 23,889 |
| Other Financing Activity | 0 | -1,234 | 0 | 0 | 0 |
| Financing Cash Flow | $N/A | $67,660 | $69,036 | $23,875 | $23,889 |
| Beginning Cash Position | 57,225 | 38,155 | 38,155 | 38,155 | 38,155 |
| End Cash Position | 49,474 | 57,225 | 69,600 | 37,126 | 51,349 |
| Net Cash Flow | $-7,752 | $19,070 | $31,445 | $-1,029 | $13,194 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,689 | -47,870 | -36,945 | -24,362 | -10,474 |
| Capital Expenditure | -54 | -720 | -646 | -543 | -221 |
| Free Cash Flow | -7,744 | -48,590 | -37,591 | -24,905 | -10,695 |